Policy▼ Bearish for Indian equities

State scrutiny of pharma price mark-ups may lead to review of TMR policy

1 source · first seen 19:40 5 Oct · updated 19:40 5 Oct

The brief

Written from 1 report · check the source before you trade

Regulators in Maharashtra, Karnataka and Uttar Pradesh are collecting data on pharma price mark-ups
The scrutiny may strengthen the case for reviewing the trade margin rationalisation policy
A TMR policy review could pressure margins for Indian pharmaceutical companies

Pick a tag to see all its stories

1 report · earliest 19:40